EyePoint Pharmaceuticals, Inc.EYPTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank93
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Percentile
P93
Near historical high
vs 2Y Ago
2.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$11.75M-22.0%
2024$15.07M+246.1%
2023$4.36M+266.4%
2022$-2.62M+16.7%
2021$-3.14M+61.2%
2020$-8.10M+9.3%
2019$-8.93M+85.9%
2018$-63.17M-134.8%
2017$-26.90M-29657.1%
2016$91000.00-